BetaEntity Annotation Prototype

Biomedical literature, made navigable

Follow the entities shaping the evidence.

Discover articles through diseases, drugs, treatments, interventions, clinical instruments, institutions and funders extracted from the BMJ open corpus.

Browse by entity family

An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.

View all families
29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed

Popular entities in these results

Choose an entity to see the articles in which it was identified.

Matching articles

29,499 articles · page 378 of 2459
type 2 diabetesSGLT2iSGLT2isGLP-1RAscardiovascular and kidney diseasesGLP-1RAsodium-glucose cotransporter-2 inhibitorscardiometabolic diseasesGlucagon-like peptide-1 receptor agonistsobesity epidemic

…markably, the benefits of GLP-1RA and SGLT2i are independent of type 2 diabetes status or baseline renal function. The critical role of these d…

metastatic castration-resistant prostate cancer177Lu-oxodotreotidePluvicto177Lu-PSMALutatheraLutetium-177177Luinoperable or metastatic gastro-enteropancreatic neuroendocrine tumours

…rmaceuticals such as Pluvicto (177Lu-PSMA) for the treatment of metastatic castration-resistant prostate cancer and Lutathera (177Lu-oxodotreotide) for inoperable or metastati…